Researchers identify therapy that shrinks tumors in patients with multiple myeloma

Wednesday, March 8, 2017 - 15:31 in Health & Medicine

An experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma, report scientists.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net